## EXPE: Expedia Group, Inc. - XLY: Consumer Cyclical

### Executive Summary

VALUE thesis: PEG 0.81 indicates fundamental undervaluation. Quality metrics strong (ROE 54%). Consistent execution (4/4 quarters beat estimates). Caution: declining volume (57% of avg), momentum weakening (-3.3% MRS).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($246.21)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 5, Bearish: 3)

**1. Expedia Group Inc. stock underperforms Thursday when compared to competitors**
- Source: MarketWatch | 20251205T170808 | Bearish | Relevance: 100%
- Expedia Group Inc. (EXPE) stock dropped 1.54% on Thursday, closing at $258.38. This underperformance occurred on a mixed trading day, with the S&P 500 Index rising and the Dow Jones Industrial Average slightly falling. This marks the second consecutive day of losses for Expedia's stock.

**2. BNP Paribas Exane Starts Expedia (EXPE) Coverage Amid Travel Market Strength**
- Source: Finviz | 20251203T194200 | Bullish | Relevance: 100%
- BNP Paribas Exane initiated coverage of Expedia Group, Inc. (EXPE) with a Neutral rating, citing the company's strong third-quarter 2025 performance, which saw revenue increase by 9% to $4.4 billion and gross bookings climb by 12% to $30.7 billion. Expedia raised its full-year sales guidance to 6%-7% growth and announced a quarterly dividend of $0.40 per share, reflecting ongoing strength in the travel industry and its B2B segment. The article highlights Expedia's global travel technology operations, including brands like Expedia.com and Vrbo.

**3. BNP Paribas Exane Starts Expedia (EXPE) Coverage Amid Travel Market Strength**
- Source: Insider Monkey | 20251203T144200 | Bullish | Relevance: 100%
- BNP Paribas Exane initiated coverage of Expedia Group, Inc. (NASDAQ:EXPE) with a Neutral rating on November 24, 2025, amidst strong travel market conditions. Expedia reported robust third-quarter 2025 results, with revenue up 9% to $4.4 billion and gross bookings climbing 12% to $30.7 billion, leading to an increased full-year sales guidance and a quarterly dividend declaration of $0.40 per share. The company's B2B segment showed significant growth, contributing to its positive momentum.

**4. EXPEDIA LAUNCHES SHOPPABLE SET-JETTING TRAVEL HUB TO TURN ON-SCREEN SCENES INTO REAL-LIFE ITINERARIES**
- Source: Business Wire | 20251203T142214 | Bullish | Relevance: 100%
- Expedia has launched a new shoppable "Set-Jetting" travel hub, capitalizing on the trend of travelers booking trips inspired by TV shows and movies. The hub offers curated hotels, activities, and flights to destinations featured in popular media, as well as locations where cast members stayed during filming. This initiative aims to turn "watchlist wanderlust into real trips" for a growing number of travelers, particularly Gen Z and Millennials.

**5. EXPEDIA LAUNCHES SHOPPABLE SET-JETTING TRAVEL HUB TO TURN ON-SCREEN SCENES INTO REAL-LIFE ITINERARIES**
- Source: Markets Financial Content | 20251203T140000 | Bullish | Relevance: 100%
- Expedia has launched a new shoppable Set-Jetting travel hub, enabling travelers to book trips inspired by TV shows and movies. This initiative builds on the "Set-Jetting" trend, which has grown into a multi-billion-dollar business, primarily driven by Gen Z and Millennial travelers. The hub offers curated hotels, activities, and flights to destinations made famous by iconic on-screen scenes and characters.

### Analyst Activity

**Target Signal:** VERY_BULLISH (Raises: 15, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-17 | Mizuho | $270 | $240 | +12% |
| 2025-11-11 | Citigroup | $281 | $206 | +36% |
| 2025-11-10 | Jefferies | $270 | $220 | +23% |
| 2025-11-10 | Argus Research | $300 | $265 | +13% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-17 | Mizuho | main | Neutral |
| 2025-11-11 | Citigroup | main | Neutral |
| 2025-11-10 | Jefferies | main | Hold |
| 2025-11-10 | Argus Research | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 9 ($0.00M) |
| Sells | 10 ($2.92M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 48.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 5 |

**Top Holders:**
- Vanguard Group Inc: 13.0% (-0.7%)
- Blackrock Inc.: 8.4% (-2.5%)
- JPMORGAN CHASE & CO: 8.2% (+168.5%)
- State Street Corpora: 4.8% (-2.4%)
- Windacre Partnership: 3.1% (+9.2%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Analyst target momentum: 15 raises (avg +21%) could attract flows.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 0.81 indicates undervaluation relative to growth. Forward P/E 14.8x attractive for 18% earnings growth. Quality metrics strong (ROE 54%). Analyst sentiment positive (15 raises, avg +21%). Insider selling cluster ($2.9M in 90 days), potential headwind. Institutional flow bullish (4 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $35.6B |
| Beta | 1.44 |
| 52W Range | $130.01 - $292.42 |
| Short Interest | 7.6% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.81 |
| Forward P/E | 14.8 |
| Current P/E | 17.4 |
| YoY Growth | 17.7% |
| EPS Direction | RISING |

### Technicals

MRS_20 deteriorating from 3.7% to 0.5% (-3.3% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 3.5pp (needs >4.0% for momentum thesis). MRS_5 at 0.2% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). Volume at 57% of 20MA suggests lack of conviction. OFD pattern: +SUL (Resistance test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 0.46% (CS: 58) | Neutral |
| RSI_14 | 61.4 | Neutral |
| MACD Histogram | 0.10 | Bullish |
| vs SMA20 | 1.027x | Above |
| vs SMA50 | 1.127x | Above |
| vs SMA200 | 1.359x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $263.43
- **Stop Loss:** $246.21 (6.5% risk)
- **Target:** $297.87 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 58
- **Position Value:** $15,278.94
- **Portfolio %:** 15.28%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with balanced risk appetite. VIX near 15th percentile of 52-week range signals calm conditions, while modest yield curve steepening (54bps 10Y-3M) suggests healthy growth expectations. Breadth at 52% indicates selective participation rather than broad-based momentum.*

### Earnings

**Next:** 2026-02-05 (Est: $3.24)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $6.95 | $7.57 | +9.0% |
| 2025Q2 | $4.13 | $4.24 | +2.6% |
| 2025Q1 | $0.36 | $0.40 | +11.5% |
| 2024Q4 | $2.10 | $2.39 | +14.0% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*